APO RESEARCH · REPORT
Orally Disintegrating Tablet
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Product & engineering
Understand the product.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Selected research
Industry Research
Orally Disintegrating Tablet Industry Research Report 2026
Market perspective
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.
Report Scope
Read the full market overview
This report quantifies the global Orally Disintegrating Tablet market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Orally Disintegrating Tablet Market by Company
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Orally Disintegrating Tablet Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Orally Disintegrating Tablet Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others
Orally Disintegrating Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orally Disintegrating Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Orally Disintegrating Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orally Disintegrating Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Orally Disintegrating Tablet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Orally Disintegrating Tablet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Orally Disintegrating Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-Psychotics Drug
- Anti-Epileptics Drug
- Others
Applications
- CNS Diseases
- Gastrointestinal Diseases
- CVS Diseases
- Others
Companies covered
- Teva
- Merck
- Mylan
- Pfizer
- Johnson and Johnson
- GSK
- Otsuka
- Eli Lilly and Company
- AstraZeneca
- Bristol-Myers Squibb
- Conquer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Orally Disintegrating Tablet Market Size (2021-2032)
- 2.2.2 Global Orally Disintegrating Tablet Sales (2021-2032)
- 2.2.3 Global Orally Disintegrating Tablet Market Average Price (2021-2032)
- 2.3 Orally Disintegrating Tablet by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Anti-Psychotics Drug
- 2.3.3 Anti-Epileptics Drug
- 2.3.4 Others
- 2.4 Orally Disintegrating Tablet by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 CNS Diseases
- 2.4.3 Gastrointestinal Diseases
- 2.4.4 CVS Diseases
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Orally Disintegrating Tablet Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Orally Disintegrating Tablet Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Orally Disintegrating Tablet Revenue of Manufacturers (2021-2026)
- 3.4 Global Orally Disintegrating Tablet Average Price by Manufacturers (2021-2026)
- 3.5 Global Orally Disintegrating Tablet Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Orally Disintegrating Tablet, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Orally Disintegrating Tablet, Product Type & Application
- 3.8 Global Manufacturers of Orally Disintegrating Tablet, Established Date
- 3.9 Global Orally Disintegrating Tablet Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Orally Disintegrating Tablet Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck Orally Disintegrating Tablet Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Orally Disintegrating Tablet Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Orally Disintegrating Tablet Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Johnson and Johnson
- 4.5.1 Johnson and Johnson Company Information
- 4.5.2 Johnson and Johnson Business Overview
- 4.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Johnson and Johnson Orally Disintegrating Tablet Product Portfolio
- 4.5.5 Johnson and Johnson Recent Developments
- 4.6 GSK
- 4.6.1 GSK Company Information
- 4.6.2 GSK Business Overview
- 4.6.3 GSK Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GSK Orally Disintegrating Tablet Product Portfolio
- 4.6.5 GSK Recent Developments
- 4.7 Otsuka
- 4.7.1 Otsuka Company Information
- 4.7.2 Otsuka Business Overview
- 4.7.3 Otsuka Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Otsuka Orally Disintegrating Tablet Product Portfolio
- 4.7.5 Otsuka Recent Developments
- 4.8 Eli Lilly and Company
- 4.8.1 Eli Lilly and Company Company Information
- 4.8.2 Eli Lilly and Company Business Overview
- 4.8.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Eli Lilly and Company Orally Disintegrating Tablet Product Portfolio
- 4.8.5 Eli Lilly and Company Recent Developments
- 4.9 AstraZeneca
- 4.9.1 AstraZeneca Company Information
- 4.9.2 AstraZeneca Business Overview
- 4.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AstraZeneca Orally Disintegrating Tablet Product Portfolio
- 4.9.5 AstraZeneca Recent Developments
- 4.10 Bristol-Myers Squibb
- 4.10.1 Bristol-Myers Squibb Company Information
- 4.10.2 Bristol-Myers Squibb Business Overview
- 4.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet Product Portfolio
- 4.10.5 Bristol-Myers Squibb Recent Developments
- 4.11 Conquer
- 4.11.1 Conquer Company Information
- 4.11.2 Conquer Business Overview
- 4.11.3 Conquer Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Conquer Orally Disintegrating Tablet Product Portfolio
- 4.11.5 Conquer Recent Developments
5 Global Orally Disintegrating Tablet Market Scenario by Region
- 5.1 Global Orally Disintegrating Tablet Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Orally Disintegrating Tablet Sales by Region: 2021-2032
- 5.2.1 Global Orally Disintegrating Tablet Sales by Region: 2021-2026
- 5.2.2 Global Orally Disintegrating Tablet Sales by Region: 2027-2032
- 5.3 Global Orally Disintegrating Tablet Revenue by Region: 2021-2032
- 5.3.1 Global Orally Disintegrating Tablet Revenue by Region: 2021-2026
- 5.3.2 Global Orally Disintegrating Tablet Revenue by Region: 2027-2032
- 5.4 North America Orally Disintegrating Tablet Market Facts & Figures by Country
- 5.4.1 North America Orally Disintegrating Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Orally Disintegrating Tablet Sales by Country (2021-2032)
- 5.4.3 North America Orally Disintegrating Tablet Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Orally Disintegrating Tablet Market Facts & Figures by Country
- 5.5.1 Europe Orally Disintegrating Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Orally Disintegrating Tablet Sales by Country (2021-2032)
- 5.5.3 Europe Orally Disintegrating Tablet Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Orally Disintegrating Tablet Market Facts & Figures by Country
- 5.6.1 Asia Pacific Orally Disintegrating Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Orally Disintegrating Tablet Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Orally Disintegrating Tablet Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Orally Disintegrating Tablet Market Facts & Figures by Country
- 5.7.1 South America Orally Disintegrating Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Orally Disintegrating Tablet Sales by Country (2021-2032)
- 5.7.3 South America Orally Disintegrating Tablet Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Orally Disintegrating Tablet Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Orally Disintegrating Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Orally Disintegrating Tablet Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Orally Disintegrating Tablet Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Orally Disintegrating Tablet Sales by Type (2021-2032)
- 6.1.1 Global Orally Disintegrating Tablet Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Orally Disintegrating Tablet Sales Market Share by Type (2021-2032)
- 6.2 Global Orally Disintegrating Tablet Revenue by Type (2021-2032)
- 6.2.1 Global Orally Disintegrating Tablet Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Orally Disintegrating Tablet Revenue Market Share by Type (2021-2032)
- 6.3 Global Orally Disintegrating Tablet Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Orally Disintegrating Tablet Sales by Application (2021-2032)
- 7.1.1 Global Orally Disintegrating Tablet Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Orally Disintegrating Tablet Sales Market Share by Application (2021-2032)
- 7.2 Global Orally Disintegrating Tablet Revenue by Application (2021-2032)
- 7.2.1 Global Orally Disintegrating Tablet Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Orally Disintegrating Tablet Revenue Market Share by Application (2021-2032)
- 7.3 Global Orally Disintegrating Tablet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Orally Disintegrating Tablet Value Chain Analysis
- 8.1.1 Orally Disintegrating Tablet Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Orally Disintegrating Tablet Production Mode & Process
- 8.2 Orally Disintegrating Tablet Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Orally Disintegrating Tablet Distributors
- 8.2.3 Orally Disintegrating Tablet Customers
9 Global Orally Disintegrating Tablet Analyzing Market Dynamics
- 9.1 Orally Disintegrating Tablet Industry Trends
- 9.2 Orally Disintegrating Tablet Industry Drivers
- 9.3 Orally Disintegrating Tablet Industry Opportunities and Challenges
- 9.4 Orally Disintegrating Tablet Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst